Michael heads up the Life Sciences & Healthcare industry group and with around 20 years of experience, he is a proven specialist and solution-oriented negotiator for complex M&A and private equity transactions. Michael takes up the challenge of complex situations in the interests of his clients.
His portfolio includes advice on large corporate transactions acting either on the side of the buyer or the seller, but also on restructuring, joint ventures, minority shareholdings, management investments and general corporate law issues. Michael represents the interests of strategic and financial investors from Germany and abroad, including hospital operators, medical care centre operators, medical technology and life sciences companies, and other healthcare providers - a range that reflects his strong industry expertise.
|Since 2010||Partner, Taylor Wessing|
|2007 – 2010||Counsel, area of Corporate M&A/Private Equity, Lovells LLP (today Hogan Lovells International LLP), Frankfurt am Main|
|2001 – 2007||Associate, area of Corporate M&A/Private Equity, Lovells LLP (today Hogan Lovells International LLP), Frankfurt am Main|
|2005||Associate, area of Private Equity, Lovells LLP (today Hogan Lovells International LLP), London/UK|
|2001||Admitted and established as a lawyer, Frankfurt am Main|
|2000||Second state examination, Koblenz|
|1998||First state examination, Trier|
|1995 – 1996||Course of study, Seville, Spain|
|1993 – 1998||Degree, Law, Trier|
Anmerkung zu BGH-Urteil vom 11.12.2006 – II ZR 243/05, Haftung eines fakultativen Aufsichtsrats einer GmbH, DZWiR 2007, 327 ff.